Emergency medicine specialist Lauren Sauer tells 'Bloomberg' that although the setback delays coronavirus vaccine development, the final product will be safer for the public
/ Bloomberg
Bloomberg Distinguished Professor with appointments in the Carey Business School and Bloomberg School of Public Health joins a panel of experts who will advise policymakers on the fair allocation of COVID-19 vaccines
Johns Hopkins lecturer Bonnie Robeson, who led drug discovery and development during AIDS epidemic, shares why scientists should prioritize finding a suitable therapy for COVID-19 as well as a vaccine
Supriya Munshaw, an expert in the commercialization of early-stage technologies at the Johns Hopkins Carey Business School, discusses the process of developing a vaccine for COVID-19
Engineer Russell Taylor and a group of students design a device to make it easier for biotech company Sanaria to develop a malaria vaccine
/ Johns Hopkins Magazine
PERCH study, led by researchers at the Bloomberg School of Public Health, highlights the need for new vaccines, especially for respiratory synctial virus